Cryofibrinogen-associated membranoproliferative glomerulonephritis
Kidney International · 2023
DOI: 10.1016/j.kint.2023.05.004 ↗Kurz gefasst
Fallbericht in der Zeitschrift Kidney International, 2023. Verfasst von Minah Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun, Republic of Korea. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranoproliferative. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun, Republic of Korea.
- Department of Pathology, Chonnam National University Medical School, Gwangju, Republic of Korea.
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea; Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea; Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea. Electronic addr…
Zitieren
APA
Kim, M., Kim, S. S., Choi, H. I., Choi, H. S., Bae, E. H., Ma, S. K., Kim, S. W., & Kim, C. S. (2023). Cryofibrinogen-associated membranoproliferative glomerulonephritis. Kidney International. https://doi.org/10.1016/j.kint.2023.05.004
Vancouver
Kim M, Kim SS, Choi HI, Choi HS, Bae EH, Ma SK, et al. Cryofibrinogen-associated membranoproliferative glomerulonephritis. Kidney International. 2023. doi:10.1016/j.kint.2023.05.004
BibTeX
@article{Kim2023,
author = {Kim, Minah and Kim, Sung Sun and Choi, Hoon-In and Choi, Hong Sang and Bae, Eun Hui and Ma, Seong Kwon and Kim, Soo Wan and Kim, Chang Seong},
title = {Cryofibrinogen-associated membranoproliferative glomerulonephritis},
journal = {Kidney International},
year = {2023},
doi = {10.1016/j.kint.2023.05.004}
}
EUVIMED